Literature DB >> 12645653

Chromosomal alterations in osteosarcoma cell lines revealed by comparative genomic hybridization and multicolor karyotyping.

Toshifumi Ozaki1, Thomas Neumann, Daniel Wai, Karl-Ludwig Schäfer, Franz van Valen, Norbert Lindner, Christina Scheel, Wermer Böcker, Winfried Winkelmann, Barbara Dockhorn-Dworniczak, Jürgen Horst, Christopher Poremba.   

Abstract

We characterized the chromosomal alterations in eight osteosarcoma cell lines (OST, HOS, U-2 OS, ZK-58, MG-63, SJSA-1, Saos-2, and MNNG) by comparative genomic hybridization (CGH); gains and losses of DNA sequences were defined as chromosomal regions with a fluorescence ratio, wherein all of the 95% confidence interval was above 1.25 and below 0.75, respectively. In four of 8 cell lines, multicolor karyotyping (MK) was added. CGH revealed the average number of aberrations per cell line was 20.8 (range: 10-31); the average numbers of gains and losses were 11.1 and 9.6, respectively. The frequent gains were identified on 1p21 approximately q24, 1q25-q31, 7p21, 7q31, 8q23 approximately q24, and 14q21; frequent losses were at 18q21 approximately q22, 18q12, 19p, and 3p12 approximately p14. High-level gains were observed on 8q23 approximately q24, 5p, and 1p21 approximately p22. MK revealed the most common translocations in the four cell lines were t(8;9), t(1;3), t(3;5), t(1;13), t(2;6), t(3; 17), t(1;15), t(10;20), and t(6;20). Chromosomes 1, 3, 8, 9, and 20 were most frequently involved in translocation events. The concordance rate of aberrations in CGH and translocations in MK was 76%. MK was useful to identify the chromosomal alterations and as a supplement to the CGH results in three of four chromosomes.

Entities:  

Mesh:

Year:  2003        PMID: 12645653     DOI: 10.1016/s0165-4608(02)00685-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

Review 1.  Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives.

Authors:  Pete Anderson; Maritza Salazar-Abshire
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

2.  Down-regulation of ribosomal protein L7A in human osteosarcoma.

Authors:  Shui-er Zheng; Yang Yao; Yang Dong; Feng Lin; Hui Zhao; Zan Shen; Yuan-jue Sun; Li-na Tang
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-06       Impact factor: 4.553

3.  Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma.

Authors:  Georges Maire; Maisa Yoshimoto; Susan Chilton-MacNeill; Paul S Thorner; Maria Zielenska; Jeremy A Squire
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

4.  Ladder-like amplification of the type I interferon gene cluster in the human osteosarcoma cell line MG63.

Authors:  Narasimharao V Marella; Michael J Zeitz; Kishore S Malyavantham; Artem Pliss; Sei-ichi Matsui; Sandra Goetze; Juergen Bode; Ivan Raska; Ronald Berezney
Journal:  Chromosome Res       Date:  2008-11-15       Impact factor: 5.239

5.  A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer.

Authors:  Eike Staub; Jörn Gröne; Detlev Mennerich; Stefan Röpcke; Irina Klamann; Bernd Hinzmann; Esmeralda Castanos-Velez; Benno Mann; Christian Pilarsky; Thomas Brümmendorf; Birgit Weber; Heinz-Johannes Buhr; André Rosenthal
Journal:  Mol Cancer       Date:  2006-09-18       Impact factor: 27.401

6.  Development of a New Monochrome Multiplex qPCR Method for Relative Telomere Length Measurement in Cancer.

Authors:  Paige N Dahlgren; Kanokwan Bishop; Shatovisha Dey; Brittney-Shea Herbert; Hiromi Tanaka
Journal:  Neoplasia       Date:  2018-03-21       Impact factor: 5.715

7.  Expression and differential regulation of human TERRA at several chromosome ends.

Authors:  Marianna Feretzaki; Patricia Renck Nunes; Joachim Lingner
Journal:  RNA       Date:  2019-07-26       Impact factor: 4.942

8.  Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors.

Authors:  Masahiko Kanamori; Akimi Sano; Taketoshi Yasuda; Takeshi Hori; Kayo Suzuki
Journal:  J Exp Clin Cancer Res       Date:  2012-11-30

9.  In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma.

Authors:  Bekim Sadikovic; Maisa Yoshimoto; Khaldoun Al-Romaih; Georges Maire; Maria Zielenska; Jeremy A Squire
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

10.  Establishment of a new human osteosarcoma cell line, UTOS-1: cytogenetic characterization by array comparative genomic hybridization.

Authors:  Taketoshi Yasuda; Masahiko Kanamori; Shigeharu Nogami; Takeshi Hori; Takeshi Oya; Kayo Suzuki; Tomoatsu Kimura
Journal:  J Exp Clin Cancer Res       Date:  2009-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.